Paglia John Kenneth sold (to issuer) $270K of SLP
Paglia John Kenneth sold (to issuer) 14,589 shares of Simulations Plus, Inc. (SLP) at $18.50 ($0.27M total) on 2026-10-06.
How this was made
The 30-second read
Why it matters
The disclosure provides fresh data for traders monitoring insider activity, though the monetary size is modest.
Market read
A primary-source insider sale that may cause slight negative sentiment for SLP.
What to watch
Potential tax planning or diversification motives for the director.
Background
SEC Form 4 filing discloses insider transactions; this is the first public report of the director's sale.
Ticker impact
Director John Kenneth Paglia sold 14,589 shares for $269,896, leaving a zero shareholding.
likely slight pressure as the market prices the director's exit
A director disposing of his entire stake signals reduced confidence; the amount is modest but may affect sentiment.
Market effects
Minimal impact on the broader biotech/software sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be a routine liquidity move, not a negative signal.
Key entities
- companySimulations Plus, Inc.
Biotech software provider listed on NASDAQ under SLP.
- personJohn Kenneth Paglia
Director of Simulations Plus who sold his entire shareholding.